The study presents spine fusion using osteoconductive mesenchymal stem cells as a safe alternative to fusions using Bone Morphogenetic Protein (BMP). The study has also been selected to appear as an online supplement to the European Journal of Neurology.
Read the KTBS report on Dr. Eubulus J. Kerr.
Read other coverage on spine surgery:
– 3 Cutting-Edge Projects at the Southern California Center for Neuroscience and Spine
– Latest Trends in Spine Surgery Techniques: Laser and Stem Cell Technology
– Spine Surgery Research Update: Biologics in Spine Surgery
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
